155790-03-7

Basic information

• Product Name: 2,3-Pyridinediamine,N3,6-dimethyl-(9CI)
• Synonyms: 2,3-Pyridinediamine,N3,6-dimethyl-(9CI);N3,6-DiMethylpyridine-2,3-diaMine
• CAS NO: 155790-03-7
• Molecular Formula: C₇H₁₁N₃
• Molecular Weight: 137.18234
• Product Categories: PYRIDINE
• Mol File: 155790-03-7.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2,3-Pyridinediamine,N3,6-dimethyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-Pyridinediamine,N3,6-dimethyl-(9CI)(155790-03-7)
• EPA Substance Registry System: 2,3-Pyridinediamine,N3,6-dimethyl-(9CI)(155790-03-7)

Safety Data

• Hazardous Substances Data: 155790-03-7(Hazardous Substances Data)

Usage

Appearance

white to light yellow solid

Melting point

117-121°C

Solubility

sparingly soluble in water
Requires cautious handling and proper safety procedures to prevent hazards

Upstream product

• 155789-93-8 6-methyl-3-methylamino-2-nitropyridine 
• 15128-90-2 6-methyl-2-nitropyridin-3-ol 
• 24015-98-3 3-methoxy-6-methyl-2-nitro-pyridine 
• 1121-78-4 5-Hydroxy-2-methylpyridine 

Downstream Products

• 211915-58-1 1,5-Dimethyl-2-[(4-cyanophenyl)oxymethyl]-imidazo[4,5-b]-pyridine 
• 155789-81-4 2-amino-1,5-dimethylimidazo<4,5-b>pyridine 

Relevant articles and documents

Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions

New disubstituted bicyclic heterocycles of general formula Ra-A-Het-B-Ar-E (I)Compounds of the above general formula I, wherein E denotes an RbNH-C(=NH)- group, have valuable pharmacological properties, particularly a thrombin-inhibiting effect and the effect of prolonging thrombin time, and those wherein E denotes a cyano group, are valuable intermediates for preparing the other compounds of general formula I. Exemplary compounds of formula I are: (a) 1-Methyl-2-[N-(4-amidinophenyl)-aminomethyl]-benzimidazol-5-yl-carboxylic acid-N-phenyl-N-(2-hydroxycarbonylethyl)-amide, (b) 1-Methyl-2-[N-(4-amidinophenyl)-aminomethyl]-benzimidazol-5-yl-carboxylic acid-N-(2-pyridyl)-N-(hydroxycarbonylmethyl)-amide, (c) 1-Methyl-2-[N-(4-amidino-2-methoxy-phenyl)-aminomethyl]-benzimidazol-5-yl-carboxylic acid-N-(2-pyridyl)-N-(hydroxycarbonylmethyl)-amide, and (d) 1-Methyl-2-[N-[4-(N-n-hexyloxycarbonylamidino)phenyl]aminomethyl]-benzimidazol-5-yl-carboxylic acid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl) amide.